News and Announcements

Tim Mastro's profile
Don't miss our latest published research list
July 26, 2017

Dr. Timothy Mastro, Chief Science Officer, describes his top three picks from the latest published research from FHI 360.

Conference Logo
IAS 2017: New insights for efficient HIV program implementation
July 19, 2017

FHI 360 will be participating in the International AIDS Society Conference on HIV Science. IAS 2017 is a crucial point when the scientific advances within the HIV response are center stage. The focus at IAS 2017 will be on new insights that will enable programs to efficiently implement prevention, treatment, care and support services with impact on epidemic control at the forefront.

Read More
woman smiling after receiving injection
Levoplant, two-rod contraceptive implant, receives World Health Organization prequalification
July 05, 2017

FHI 360 congratulates its partner, Shanghai Dahua Pharmaceutical Co., Ltd. (Dahua), on achieving prequalification from the World Health Organization (WHO) of its two-rod contraceptive implant, Levoplant, which is also referred to as Sino-implant (II). By attaining WHO prequalification, Levoplant/Sino-implant (II) is now recognized as meeting international quality standards.

Read More

Partner With Us

FHI 360’s work is made possible through the support of our many funders and partners.
Here are a few examples.